Firm Memoranda
- FTC Announces Final Changes to Premerger Notification Form
10.28.2024
- Sixth Circuit Upholds SEC’s Proxy Advisor Rule Repeal, Creating Split With Fifth Circuit
10.15.2024
- First Department Clarifies “Substantial Basis” Standard Under New York’s Anti-SLAPP Statute
10.10.2024
- Broker-Dealer Crypto Asset Activities and Best Practices
09.26.2024
- “Unclear at Best”: SEC v. Payward, Inc. et al. and the Ongoing Struggle to Understand Secondary Crypto Transactions
09.05.2024
- FTC Non-Compete Rule Update: Texas District Court Blocks Rule’s Implementation on a Nationwide Basis
09.04.2024
- Delaware Corporate Statute Amended to Override Much of Recent Chancery Court Decision Invalidating Certain Stockholder Agreement Corporate Governance Provisions
07.30.2024
- FTC Non-Compete Rule Update: Uncertainty Remains as Federal District Courts Issue Conflicting Preliminary Injunction Rulings
07.29.2024
- SEC Division of Corporation Finance Issues Additional Guidance Relating to Cybersecurity Incident Disclosure
07.15.2024
- Supreme Court says Timing is Everything for Bribes and Gratuities
07.12.2024
- SEC v. Binance: The Dis-Embodiment of Howey?
07.02.2024
- SEC and CFTC Step Up Enforcement of Whistleblower Protection in Confidentiality Agreements
06.28.2024
- New York First Department Clarifies the Applicability of New York’s Anti-SLAPP Statute
06.21.2024
- The Federal Circuit’s New Nonobviousness Standard For Design Patents
06.10.2024
- Supreme Court Unanimously Holds that Pure Omissions Cannot Sustain a Private Claim Under SEC Rule 10b-5(b)
05.22.2024
- The Walking Dead: “Open Internet” Rules Live Again
05.22.2024
- FTC Approves Final Rule Prohibiting Worker Non- Competes...and is Immediately Challenged in Court
05.20.2024
- Supreme Court Adopts New Test to Determine When a Public Official’s Social Media Use Constitutes State Action For First Amendment Purposes
05.13.2024
- Congress Extends Statute of Limitations for Violations of U.S. Sanctions to Ten Years
05.02.2024
- Ninth Circuit Rules That Biopharmaceutical Company’s Announcement of COVID-19 “Cure” Did Not Violate Securities Laws
05.02.2024
Load More
Sign up for Cahill Publications
Julie Cohen
Director of Marketing and Communications
212.701.3614
jcohen@cahill.com